CAS: 2088735-51-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | FLT3-IN-10 REF: IN-DA024D2YCAS: 2088735-51-5 | 98% | To inquire | Wed 16 Apr 25 |
 | FLT3-IN-10 REF: 54-BUP08248CAS: 2088735-51-5 | 99.6% | 394.00 €~1,085.00 € | Thu 17 Apr 25 |
 | FLT3-IN-10 REF: TM-T9856CAS: 2088735-51-5 | 99.60% | 38.00 €~1,782.00 € | Thu 17 Apr 25 |
Ref: IN-DA024D2Y
| 10mg | 505.00 € | ||
| 25mg | 677.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 16 Apr 2025
Ref: 54-BUP08248
| 25mg | 394.00 € | ||
| 50mg | 571.00 € | ||
| 100mg | 813.00 € | ||
| 200mg | 1,085.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025
FLT3-IN-10
CAS:2088735-51-5
FLT3-IN-10, a potent FLT3 inhibitor, may treat FLT3-mutated AML.
Formula:
C15H11FN2O
Purity:
99.60%
Color and Shape:
Solid
Molecular weight:
254.26
Ref: TM-T9856
| 1mg | 38.00 € | ||
| 5mg | 85.00 € | ||
| 10mg | 131.00 € | ||
| 25mg | 259.00 € | ||
| 50mg | 383.00 € | ||
| 100mg | 545.00 € | ||
| 200mg | 740.00 € | ||
| 1mL*10mM (DMSO) | 81.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025
